For treating and preventing bleeding episodes in people 2 years and over with haemophilia A (congenital factor VIII deficiency), only if:
they have a factor VIII activity level of less than 1% (severe haemophilia A)
the company provides it according to the commercial arrangement
(NICE TA1051)
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 10 ampoule |
| Pack |
|---|
| 10 ampoule |
| 20 ampoule |
| Pack |
|---|
| 10 ampoule |
| 20 ampoule |
| 50 ampoule |
| Pack |
|---|
| 10 ampoule |
| 20 ampoule |
| 50 ampoule |
| 100 ampoule |
| Pack |
|---|
| 10 ampoule |
| 20 ampoule |
| Pack |
|---|
| 10 ampoule |




